Wormser Freres Gestion’s Edwards Lifesciences EW Stock Holding History

Wormser Freres Gestion’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.54M	Buy	90,770 +1,860	+2%	+$156K	4.83%	12
2026 Q1	$7.28M	Sell	88,910 -2,941	-3%	-$242K	5.25%	10
2025 Q4	$7.83M	Sell	91,851 -2,683	-3%	-$220K	4.45%	13
2025 Q3	$7.39M	Buy	94,534 +3,141	+3%	+$245K	4.11%	12
2025 Q2	$7.15M	Sell	91,393 -399	-0.4%	-$29.8K	4.25%	13
2025 Q1	$6.53M	Sell	91,792 -328	-0.4%	-$23.5K	4%	13
2024 Q4	$6.89M	Sell	92,120 -103	-0.1%	-$7.21K	4.1%	15
2024 Q3	$6.1M	Buy	92,223 +1,751	+2%	+$127K	3.73%	15
2024 Q2	$8.63M	Sell	90,472 -980	-1%	-$86.8K	5.63%	8
2024 Q1	$8.9M	Buy	91,452 +40,073	+78%	+$3.37M	6.09%	5
2023 Q4	$3.95M	Buy	+51,379	New	+$3.57M	3.2%	14

Other funds holding EW

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

BHIA

Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return

NONA

Ninety One North America New York $2.13B AUM 9.16% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

SIM

Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return

OIAM

OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return

FFM

Fisher Funds Management Auckland, New Zealand $3.52B AUM 17.59% 1-Year Est. Return

Wormser Freres Gestion's EW Position: Q2 2026 in Review

Wormser Freres Gestion increased its Edwards Lifesciences (EW) stake by 2.1% in Q2 2026, buying an estimated $156K and bringing the position to 90,770 shares worth $8.54M. The position accounts for 4.83% of the portfolio, ranked #12.

Wormser Freres Gestion first reported a position in EW in Q4 2023 and has held it in 11 quarters since. The position peaked at $8.9M in Q1 2024. 257 funds tracked by Wall St. Rank hold EW as of Q2 2026.

Wormser Freres Gestion held 90,770 shares of Edwards Lifesciences worth $8.54M as of Q2 2026.
Wormser Freres Gestion bought 1,860 Edwards Lifesciences shares in Q2 2026, an estimated $156K.
Edwards Lifesciences made up 4.83% of Wormser Freres Gestion's portfolio in Q2 2026, its #12 holding.
Wormser Freres Gestion first reported a position in Edwards Lifesciences in Q4 2023 and has held it in 11 quarters since.
Wormser Freres Gestion's Edwards Lifesciences position peaked at $8.9M in Q1 2024.
257 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Wormser Freres Gestion's 13F filing for Q2 2026, filed 16 Jul 2026.